Topic
Recovery & Immune Peptides
6 articles.
BPC-157: What the Research Actually Says
BPC-157 research explained: mostly animal studies, very little human data, no FDA approval, and where its 2026 compounding status stands in plain English.
Recovery & Immune PeptidesTB-500 and Thymosin Beta-4 Explained
TB-500 and thymosin beta-4 are not the same thing. Learn how they differ, what human research exists, FDA status in 2026, and why TB-500 safety is unknown.
Recovery & Immune PeptidesGHK-Cu Copper Peptide for Skin and Hair
GHK-Cu copper peptide shows up in serums and clinic menus. Here is what the research on skin and hair actually shows, plus its current FDA status in 2026.
Recovery & Immune PeptidesKPV and LL-37: Immune Peptides 101
KPV and LL-37 are immune peptides with interesting lab research but little human evidence. Learn what they are, what studies show and their 2026 FDA status.
Recovery & Immune PeptidesThymosin Alpha-1: Approved Abroad, Not in the US
Thymosin alpha-1 is approved in dozens of countries but not by the FDA. Learn what it is, what studies show and why US approval never came so far.
Recovery & Immune PeptidesPeptides and Athletes: What WADA Prohibits
Which peptides does WADA prohibit? A plain-English guide to the 2026 Prohibited List for athletes, covering BPC-157, TB-500, GH peptides, MOTS-c and GLP-1s.